SAGE launches new open access journal: Cardiovascular and Thoracic Open

SAGE, one of the world's leading independent and academic publishers, has launched a new open access journal Cardiovascular and Thoracic Open (CTO). Aimed at surgeons and medical professionals alike, this international, open access, peer-reviewed journal will publish research from around the world pertaining to cardiovascular and thoracic medicine.

Cardiovascular and Thoracic Open provides a platform for rapid publication for cardiovascular and thoracic surgeons, cardiologists, and allied health care professionals globally - an international forum to discuss the diagnoses and treatment of cardiovascular and thoracic diseases. This OA journal will be available globally, powered by HighWire.

Editor A. Sampath Kumar of Pushpanjali Crosslay Hospital, India, commented that:

"The field of cardiovascular and thoracic disease is one that continues to develop with medical advances. This new journal will provide a pivotal platform for the global discussion of both its diagnosis and treatment. With SAGE's ever expanding medical portfolio and its vast international connections we are excited to see the impact that this journal will have on global debates and development."

Karen Phillips, Editorial Director, SAGE, further remarked on the launch:

"Cardiovascular and Thoracic Open is an exciting launch for us at SAGE. Since our founding, 50 years ago, SAGE has developed an extensive and leading medical portfolio and with CTO we are aiming to provide an innovative OA forum in which to support the development of and the engagement with this impactful area of medical research. We look forward to working with the coveted editorial board and to seeing the global development of the journal and research field."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research suggests no need for yellow fever vaccine booster after initial dose